ANACIN EXTRA STRENGTH 500 MG — DIN 02332469
ACETYLSALICYLIC ACID : 500 MG CAFFEINE : 32 MG · PALADIN PHARMA INC. · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is ANACIN EXTRA STRENGTH?
ANACIN EXTRA STRENGTH 500 MG contains ACETYLSALICYLIC ACID : 500 MG CAFFEINE : 32 MG. It is listed in the Health Canada Drug Product Database under DIN 02332469, held by PALADIN PHARMA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 29-May-2019. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Acetylsalicylic Acid, Comb Excl Psycholeptics in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
26 holders have a Canadian DIN containing Acetylsalicylic Acid, Comb Excl Psycholeptics, across 54 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| BAYER INC CONSUMER CARE | 10 | 0 | ALKA-SELTZER FLAVOURED - EVT, ALKA-SELTZER MORNING RELIEF, ALKA-SELTZER PLUS COLD MEDICINE - EVT, ASPIRIN PLUS STOMACH GUARD EXTRA STRENGTH, ASPIRIN WITH STOMACH GUARD, +5 more | No marketed DIN |
| BAYER INC | 4 | 0 | ALKA-SELTZER, ALKA-SELTZER FLAVOURED, ASPIRIN RAPID RELIEF, EXTRA STRENGTH MIDOL RELIEF | No marketed DIN |
| STERLING WINTHROP INC. | 4 | 0 | ASPIRIN PLUS STOMACH GUARD EXT.STGTH.CAPLET, ASPIRIN PLUS STOMACH GUARD TAB, INSTANTINE TAB, MIDOL TAB | No marketed DIN |
| WYETH CONSUMER HEALTHCARE INC. | 4 | 0 | ANACIN CAPLETS, ANACIN EXTRA STRENGTH CAPLETS, ANACIN EXTRA STRENGTH TABLET, ANACIN TABLET | No marketed DIN |
| MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | 3 | 0 | ALKA SELTZER EVT, ALKA SELTZER FLAVOURED, ALKA SELTZER PLUS COLD MEDICINE EVT | No marketed DIN |
| PALADIN PHARMA INC. | 3 | 0 | ANACIN CAPLETS, ANACIN EXTRA STRENGTH, ANACIN EXTRA STRENGTH CAPLETS | No marketed DIN |
| SCHERING-PLOUGH CANADA INC | 3 | 0 | CORICIDIN D TAB, CORICIDIN ND TAB, CORICIDIN TAB | No marketed DIN |
| J L MATHIEU CIE LTEE | 2 | 0 | NERVINE, NERVINE TAB | No marketed DIN |
| LES PRODUITS GERBEX INC. | 2 | 0 | ANTIDOL TABLETS, NEZGER TAB | No marketed DIN |
| MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | 2 | 0 | 217, 217 STRONG TAB | No marketed DIN |
| ZEE MEDICAL | 2 | 0 | PAIN AID, TRI-BUFFERED ASA TAB | No marketed DIN |
| HERBES UNIVERSELLES INC. | 1 | 0 | HERBOPYRINE TAB 325MG | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 500 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Acetylsalicylic Acid, Comb Excl Psycholeptics |
|---|---|
| ATC code | N02BA51 |
| AHFS class | 28:08.04.24 ; 28:20.32 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02332469 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2332469 |
| Brand name | ANACIN EXTRA STRENGTH |
| Generic / active ingredient | ACETYLSALICYLIC ACID : 500 MG CAFFEINE : 32 MG |
| Market authorization holder | PALADIN PHARMA INC. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | N02BA51 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N02BA |
| Current status | CANCELLED POST MARKET |
| Status date | 29-May-2019 |
| Original market date | 2011-06-16 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 54 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| 217 | 325 MG | TABLET | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | CANCELLED POST MARKET | 00666645 |
| 217 STRONG TAB | 30 MG | TABLET | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | CANCELLED POST MARKET | 00259802 |
| ALKA SELTZER EVT | 1.916 G | TABLET (EFFERVESCENT) | MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | CANCELLED POST MARKET | 00623008 |
| ALKA SELTZER FLAVOURED | 1.71 G | TABLET (EFFERVESCENT) | MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | CANCELLED POST MARKET | 00709077 |
| ALKA SELTZER PLUS COLD MEDICINE EVT | 325 MG | TABLET (EFFERVESCENT) | MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | CANCELLED POST MARKET | 01919261 |
| ALKA-SELTZER | 1000 MG | TABLET (EFFERVESCENT) | BAYER INC | CANCELLED POST MARKET | 02152746 |
| ALKA-SELTZER FLAVOURED | 1700 MG | TABLET (EFFERVESCENT) | BAYER INC | CANCELLED POST MARKET | 02245367 |
| ALKA-SELTZER FLAVOURED - EVT | 325 MG | TABLET (EFFERVESCENT) | BAYER INC CONSUMER CARE | CANCELLED POST MARKET | 02152754 |
| ALKA-SELTZER MORNING RELIEF | 500 MG | TABLET (EFFERVESCENT) | BAYER INC CONSUMER CARE | CANCELLED POST MARKET | 02244451 |
| ALKA-SELTZER PLUS COLD MEDICINE - EVT | 24.1 MG | TABLET (EFFERVESCENT) | BAYER INC CONSUMER CARE | CANCELLED POST MARKET | 02152800 |
2 · Same class — other molecules in ATC N02BA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Acetylsalicylic Acid | A.S.A. · A.S.A. (ACETYLSALICYLIC ACID) TAB 325MG USP · A.S.A. 325 MG TABLET · A.S.A. 80MG ACETYLSALICYLIC ACID TABLETS · +122 more | 146 | 15 | Yes |
| Acetylsalicylic Acid, Comb With Psycholeptics | 282 MEP TAB · APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE · EQUAGESIC TABLETS · FIORINAL · +9 more | 14 | 5 | Yes |
| Acetylsalicylic Acid, Comb Excl Psycholeptics | 217 · 217 STRONG TAB · ALKA SELTZER EVT · ALKA SELTZER FLAVOURED · +48 more | 54 | 0 | Not in Canada |
| Diflunisal | DIFLUNISAL · DIFLUNISAL-250 - TAB 250MG · DIFLUNISAL-500 - TAB 500MG · DOLOBID TAB 250MG · +4 more | 10 | 0 | Not in Canada |
| Salicylic Acid And Derivatives | ARTHRITEN TABLETS · BACK-ESE M TAB 325MG · BACK-ESE M TABLETS 325 MG · DOAN'S BACKACHE PILLS 325MG · +1 more | 5 | 0 | Not in Canada |
| Sodium Salicylate | DODD'S TABLETS REGULAR STRENGTH 325 MG · DODD'S TABLETS REGULAR STRENGTH 325MG · DODDS EXTRA STRENGTH TAB 500MG · DODDS PILLS | 5 | 0 | Not in Canada |
| Salicyloylsalicylic Acid | DISALCID - TAB 500MG · DISALCID - TAB 750MG · DISALCID TAB 500MG · DISALCID TAB 750MG | 4 | 0 | Not in Canada |
| Choline Salicylate, Comb. Excl Psycholeptics | TEEJEL GEL · TRILISATE TAB | 2 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N02B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N02BE | Acetaminophen (Paracetamol) · Acetaminophen, Comb Excl Psycholeptics | 1156 | 208 |
| N02BF | Gabapentin · Pregabalin | 432 | 168 |
| N02BG | Cannabinoids · Floctafenine · Methoxyflurane | 7 | 3 |
| N02BB | Phenazone, Combinations Excl Psycholeptics | 2 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.